Resources Investment Advisors, Llc. Crispr Therapeutics Ag Transaction History

Resources Investment Advisors, Llc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$110.2 - $156.64 $172,132 - $244,671	-1,562 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$100.84 - $161.89 $111,529 - $179,050	-1,106 Reduced 41.45%	1,562 $252,000
Q1 2021 May 10, 2021	BUY	$110.72 - $210.04 $4,428 - $8,401	40 Added 1.52%	2,668 $325,000
Q4 2020 Feb 08, 2021	SELL	$79.67 - $173.23 $35,214 - $76,567	-442 Reduced 14.4%	2,628 $402,000
Q3 2020 Oct 09, 2020	SELL	$78.5 - $100.64 $118,456 - $151,865	-1,509 Reduced 32.95%	3,070 $256,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $176,291 - $348,232	4,579 New	4,579 $336,000
Q1 2020 May 14, 2020	SELL	$33.68 - $62.53 $149,909 - $278,321	-4,451 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$36.68 - $73.13 $163,262 - $325,501	4,451 New	4,451 $271,000
Q1 2019 May 10, 2019	SELL	$28.02 - $40.87 $42,030 - $61,304	-1,500 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$22.73 - $42.34 $34,095 - $63,510	1,500 New	1,500 $43,000
Q3 2018 Nov 07, 2018	SELL	$44.35 - $65.71 $4,435 - $6,570	-100 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.62 - $73.59 $4,262 - $7,359	100 New	100 $6,000

486

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

Stay updated on Resources Investment Advisors, Llc. with notifications on news.